Utility of 18 F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia
Journal of Clinical Endocrinology and Metabolism Apr 22, 2021
Long T, Hou J, Yang N, et al. - In this retrospective analysis, researchers sought to assess the effectiveness of 18 F-AlF-NOTA-octreotide ( 18 F-OC) PET/CT in detecting tumor-induced osteomalacia (TIO) and its impact on patient management. The sample consisted of 17 patients with hypophosphatemic osteomalacia suspected of TIO. 18 F-OC PET/CT study was conducted in all 17 patients to localize the tumor. The 18 F-OC PET/CT scan can help detect tumors that cause TIO. To confirm the findings, further research with a larger patient population is needed.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries